STEMI part 3 +Approach to all MIs and troponin grades + subtle STEMI cases (OMI) + LV thrombus

Sdílet
Vložit
  • čas přidán 9. 07. 2024
  • 0:00 Classification of troponin zones, Hs-troponin T vs Hs-troponin I, General approach to all forms of myocardial injury and use of troponin zones to help differentiate.
    12:19 Subtle STEMI cases. See also • SCAD cases and discuss... 14:25
    37:38 LV thrombus management and algorithms
    49:24 Conduction disease in STEMI

Komentáře • 14

  • @ajoydutta4133
    @ajoydutta4133 Před rokem +2

    Excellent, Waiting to hear tips and trcks of PPCI

  • @rajthapa1997
    @rajthapa1997 Před měsícem

    Thank you sir for one more clinical pearls

  • @kapteklanning
    @kapteklanning Před rokem

    Absolute gold. Many thanks for puttings these lectures on CZcams Dr. Hanna!

  • @drpnab
    @drpnab Před rokem +1

    Thank you for a wonderful lecture

  • @aroojzahid3138
    @aroojzahid3138 Před rokem

    Sir your lectures are legends . No match

  • @umerqadeer191
    @umerqadeer191 Před rokem

    Great Lecture like always. Looking forward to a lecture regarding Primary PCI.

  • @user-iq5tk4fv4r
    @user-iq5tk4fv4r Před rokem

    محاضرة رائعة يابروف ياريت حضرتك تكملناشرح علطول

  • @khalidjabr3688
    @khalidjabr3688 Před rokem

    Many thanks for this wonderful lecture,as usual 👍

  • @ahmedbakr1642
    @ahmedbakr1642 Před rokem

    briliant thank you very match

  • @namphan6911
    @namphan6911 Před rokem

    Thank you for a wonderful lecture.On the LV thrombus post AMI topic, do you use triple therapy with DAPT + OAC (VKA/NOAC) - the so called triple therapy or just a P2Y12i + OAC (VKA/NOAC), especially in AMI patients that has undergone PCI? I found this matter unclear and untouched in your lecture as well as the new book.

    • @eliashanna8248
      @eliashanna8248  Před rokem +1

      Thank you Dr Phan. Great question. There are no specific data or guidelines for LV thrombus, as I highlighted, but in regards to OAC/antiplatelet combination I extrapolate the data and guidelines for AF in PCI patients. Basically, I use triple therapy (aspirin-clopidogrel-NOAC) for 3days to 1 month, depending on the perceived coronary ischemic risk and bleeding risk (most often I use the triple combo for 2 weeks). Then, I drop aspirin and keep the double combo (OAC+ clpidogrel). This is safe from a coronary standpoint, based on AF-PCI trials. If a decision is made to stop OAC at 3 months, according to the LV thrombus features I explained, then I reintroduce aspirin (aspirin + clopidogrel).

    • @namphan6911
      @namphan6911 Před rokem +1

      @@eliashanna8248 Great answer and thank you for your reply! Such an honor to get a direct reply from the author himself. Your book is very well-known and highly recommended in my department (Interventional Cardiology at University Medical Center Ho Chi Minh City). We always encourage our fellows to look up your lectures and read your books!

    • @eliashanna8248
      @eliashanna8248  Před rokem +1

      @@namphan6911 Thank you Dr Phan for your kind words. That is great to hear.
      I try to post regular updates of my book on: sites.google.com/view/elias-hanna-book-updates/home
      Greetings to you and to all your colleagues and fellows in Ho Chi Minh City!